Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 80

Results For "MEA"

1111 News Found

FDI World Dental Federation releases statement on sustainable oral healthcare
Sustainability | March 31, 2022

FDI World Dental Federation releases statement on sustainable oral healthcare

It paves the way for an industry Code of Good Practice


BioVaxys expands cancer vaccine platform
Biotech | March 31, 2022

BioVaxys expands cancer vaccine platform

BVX-0922 to target colorectal cancer under investigator-sponsored IND


Cipla Medpro South Africa partners with mAbxience for affordable cancer drugs
News | March 31, 2022

Cipla Medpro South Africa partners with mAbxience for affordable cancer drugs

The mAbxience partnership will enable Cipla to continue its ethos of ensuring equitable access to affordable, life-saving medication


Sara Gutierrez joins SHL as the Chief Science Officer
People | March 30, 2022

Sara Gutierrez joins SHL as the Chief Science Officer

The science leader comes with a rich experience in the employment testing industry


AbbVie to showcase neuroscience portfolio at AAN 2022 annual meeting
Biotech | March 29, 2022

AbbVie to showcase neuroscience portfolio at AAN 2022 annual meeting

AbbVie to present 30 abstracts demonstrating its leadership in neuroscience, including continued migraine treatment research across the spectrum of the disease, commitment to patients with advanced Parkinson's disease, and new studies in spasticity and cervical dystonia


Vela Diagnostics launches NGS-based pan-cancer panels
Medical Device | March 28, 2022

Vela Diagnostics launches NGS-based pan-cancer panels

Vela Analytics can create concise, evidence-based in-house reports that help customers with the information to make timely, informed decisions about possible treatment options


NTT DATA launches hackathon for AI innovations in healthcare
Digitisation | March 28, 2022

NTT DATA launches hackathon for AI innovations in healthcare

Registration is open for the global event that invites technology enthusiasts to bring innovative ideas to improve healthcare outcomes


Phase 3 data show Dupixent improves signs and symptoms of prurigo nodularis
Biotech | March 27, 2022

Phase 3 data show Dupixent improves signs and symptoms of prurigo nodularis

There are currently no approved systemic treatments for prurigo nodularis; regulatory filings for prurigo nodularis planned in the first half of 2022


NATHEALTH 8th annual summit in New Delhi from March 28-29.
News | March 26, 2022

NATHEALTH 8th annual summit in New Delhi from March 28-29.

More than 120 speakers and 5,000 delegates are expected to attend


Evusheld recommended for market authorisation in EU
Biotech | March 25, 2022

Evusheld recommended for market authorisation in EU

Recommendation based on Phase III PROVENT trial showing a significant reduction in the risk of developing symptomatic COVID-19, with protection lasting at least six months